- 1
- 0
- 约 14页
- 2017-05-16 发布于上海
- 举报
Co-Crystal Screening of Diclofenac
Pharmaceutics 2011, 3, 601-614; doi:10.3390/pharmaceutics3030601
OPEN ACCESS
pharmaceutics
ISSN 1999-4923
/journal/pharmaceutics
Article
Co-Crystal Screening of Diclofenac
Christer B. Aaker?y *, Angela B. Grommet and John Desper
Department of Chemistry, Kansas State University, Manhattan, KS 66506, USA
* Author to whom correspondence should be addressed; E-Mail: aakeroy@;
Tel.: +1-785-532-6096; Fax: +1-785-532-6666.
Received: 28 June 2011; in revised form: 17 August 2011 / Accepted: 23 August 2011 /
Published: 31 August 2011
Abstract: In the pharmaceutical industry, co-crystals
您可能关注的文档
- Closure of the NCBI SRA and implications for the long-term future of genomics data storage.doc
- Cloxacillin versus vancomycin for presumed late-onset sepsis in the Neonatal Intensive Care Unit and the impact upon outcome of coagulase negative staphylococcal bacteremia a retrospective cohort study.doc
- Clouded leopard phylogeny revisited support for species recognition and population division between Borneo and Sumatra.doc
- CLUE a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department.doc
- Clues to the etiology of autoimmune diseases through analysis of immunoglobulin genes.doc
- Cluster randomisation or randomised consent as an appropriate methodology for trials in palliative care a feasibility study [ISRCTN60243484].doc
- Clustering analysis of SAGE data using a Poisson approach.doc
- CLUSFAVOR 5.0 hierarchical cluster and principal-component analysis of microarray-based transcriptional profiles.doc
- Clustering gene-expression data with repeated measurements.doc
- Clustering-based approaches to SAGE data mining.doc
原创力文档

文档评论(0)